Company Profile
Chong Kun Dang Pharm is a leading chemical company headquartered in Ansan, a central city in South Korea. Founded in 1932, the company has grown into a leading producer of pharmaceuticals, cosmetics, and other chemical products. Chong Kun Dang Pharm has a state-of-the-art manufacturing facility in the 454 Moknae-Dong area of Ansan, equipped with the latest technology and machinery to ensure the production of high-quality products.
The company's pharmaceutical division is particularly noteworthy as it produces a wide range of products, including prescription drugs, over-the-counter drugs, and dietary supplements. Chong Kun Dang Pharm's cosmetics division is also well-received as it produces a wide range of skin care and beauty products that are sought after by consumers in Korea and around the world.
In addition to its core business, Chong Kun Dang Pharm also conducts research and development activities to develop new products and technologies. The company places a strong emphasis on innovation, and its products and technologies have won numerous awards and honors.
VIEW MORE VIEW LESS
Product List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
CLAVULANATE POTASSIUM |
4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3-(2-hydroxyethylidene)-7-oxo-,potassium salt (1:1),(2R,3Z,5R)-;4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3-(2-hydroxyethylidene)-7-oxo-,monopotassium salt,[2R-(2α,3Z,5α)]-;4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3-(2-hydroxyethylidene)-7-oxo-,monopotassium salt,(2R,3Z,5R)-;Potassium clavulanate;BRL 14151K;Clavulanate potassium;Clavulanic acid potassium salt;Clavitesse;Serdaxin |
61177-45-5 | Inquiry | |
CYCLOSPORINE |
Cyclosporin;Cyclosporins |
79217-60-0 | Inquiry | |
DEMECLOCYCLINE HYDROCHLORIDE |
2-Naphthacenecarboxamide,7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-,hydrochloride (1:1),(4S,4aS,5aS,6S,12aS)-;2-Naphthacenecarboxamide,7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-,monohydrochloride;2-Naphthacenecarboxamide,7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-,monohydrochloride,[4S-(4α,4aα,5aα,6β,12aα)]-;2-Naphthacenecarboxamide,7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-,monohydrochloride,(4S,4aS,5aS,6S,12aS)-;7-Chloro-6-demethyltetracycline hydrochloride;7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride;Declomycin hydrochloride;Demeclocycline hydrochloride;Demethylchlorotetracycline hydrochloride;Ledermycin hydrochloride;6-Demethyl-7-chlorotetracycline hydrochloride;Declomycin;Meciclin;Detravis;Demetraciclina;Clortetrin |
64-73-3 | Inquiry | |
RIFAMYCINS |
Rifamycin,1,4-dideoxy-1,4-dihydro-1,4-dioxo-;2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,6,9,11(2H)-tetrone,5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-,21-acetate;Rifomycin S;2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan,rifamycin deriv.;1,4-Dideoxy-1,4-dihydro-1,4-dioxorifamycin;Rifamycin S;NSC 144130;27184-20-9;959320-39-9;1217878-21-1 |
13553-79-2 | Inquiry |